Modeling the feto-maternal interface using pluripotent stem cells Understanding endometriosis: Role of induced pluripotent stem cells Macrophages as targets for the treatment of endometriosis
SESSION IIIb: Basic Science and Medical Therapy - Carmel - Second RoomĬhallenges in translating scientific discoveries to diagnose and treat endometriosis Studying endometrial cellular plasticity and endometriosis using patient-derived organoid models Where is the evidence? The devil is under the microscope The role of neurogenic inflammation in endometriosis Preclinical organ-on-chip models of endometriosis lesions SESSION IIIa: Basic Science and Medical Therapy - Auditorium Targeting epigenetic regulators for endometriosis therapy SESSION IIb: Basic Science and Medical Therapy - Carmel - Second RoomĪI-driven early detection of endometriosis from observational clinical dataĮndometriosis & adenomyosis: Single cell genomewide approaches Menstrual fluid: non-invasive source of endometrial tissue for organoids and diagnostics Identification of a novel neuroendocrine pathway and its role in endometriosis-related infertility
Pros and Cons of Hormonal Interventions for Endometriosis Peter Gregersen, PhD and Christine Metz, PhD Single cell analysis of menstrual endometrial tissues defines phenotypes associated with endometriosis (with) Leveraging the Immune System to Treat Endometriosis SESSION IIa: Basic Science and Medical Therapy - Auditorium Amanda Chu, MD, Seckin Endometriosis Center.Karli Goldstein, MD, board member, Endometriosis Foundation of America (EndoFound).Harry Reich, MD., Honorary Medical Director Emeritus and Senior Medical Advisor to EndoFound.Piraye Beim, Ph.D., Founder and CEO, Celmatix.Tamer Seckin, MD., co-founder of Endometriosis Foundation of America (EndoFound).Dan Martin, MD., Scientific & Medical Director, Endometriosis Foundation of America (EndoFound).While COVID-19 is still among us, we are hopeful we will have a safe and productive meeting with the appropriate precautions. We have longed to have an in-person meeting where faculty and participants can talk, laugh, and brainstorm face-to-face. The two-day conference is on April 1-2, 2023 at Einhorn Auditorium, Lenox Hill Hospital, NYC. Therefore, this conference will target this important topic. While significant discoveries are being made in endometriosis at the molecular level, they have yet to be translated into tests and therapeutics that can improve the standard of care. With great excitement, we invite you to EndoFound’s 14th Annual Scientific Conference – Endometriosis 2023: From Molecular Fingerprints to Multiorgan Complex Surgery
0 kommentar(er)
